4 documents found, page 1 of 1
Early Acute Kidney Injury in Stroke Patients Submitted to Endovascular Treatmen...
Oliveira, M; Sousa, M; Antunes, R; Macedo, D; Belchior, S; Soares, D; de Oliveira Simões, F; Rocha, M; Costa, H; Novo, J; Paredes, L; Barros, PBackground/Objectives: Acute kidney injury (AKI) is a potential complication of cardiovascular disorders and is associated with worse outcome. The aim of this study was to assess the incidence of early AKI after endovascular therapy for acute ischemic stroke, identify predictors for this complication, and test the association between AKI and mortality or death or dependency. Methods: This was a single-center co...
Sex differences in axial spondyloarthritis: data from a Portuguese spondyloarth...
Cunha, RN; Sousa, E; Khmelinskii, N; Ávila, P; Couto, M; Seixas, MI; Martins, N; Bernardes, M; Martins, A; da Silva, AB; Lourenço, MH; Miguel, CBackground: Axial spondyloarthritis (axSpA), particularly ankylosing spondylitis was historically considered a male’s disease and has been under-recognized in women. Emerging evidence reveals sex differences in pathophysiology, disease presentation and therapeutic efficacy. Objective: To identify differences between sexes in a Portuguese cohort of patients with axSpA regarding clinical manifestations, disease a...
Clusters of functional status in COPD: an exploratory analysis
Rodrigues, G; Afreixo, V; Souto-Miranda, S; Machado, F; Rocha, V; Mendes, A; Martins, V; Simão, P; Marques, AFunctional status is highly meaningful to the daily life of people with COPD but is often overlooked by treatmentoptions. Understanding its heterogeneity, might contribute to better personalised care. We aimed to explore clustersof functional status in people with COPD. Lung function, impact of the disease, activity-related dyspnoea and functional status were collected cross-sectionally.The 6-minute walk test, ...
Evaluation of vancomycin MIC creep in methicillin-resistant Staphylococcus aure...
Diaz, R; Afreixo, V; Ramalheira, E; Rodrigues, C.; Gago, BVancomycin is currently the primary option treatment for methicillin-resistant Staphylococcus aureus (MRSA). However, an increasing number of MRSA isolates with high MICs, within the susceptible range (vancomycin MIC creep), are being reported worldwide. Resorting to a meta-analysis approach, this study aims to assess the evidence of vancomycin MIC creep.